Description

The LigaSure Atlas Hand Switching Tissue Fusion Instrument by Covidien is an advanced surgical tool engineered for both open and laparoscopic procedures. This single-use device excels in vessel sealing and tissue division, offering seamless integration of sealing and cutting functions within one instrument.

Key Features

• Ergonomic Design: The device is designed for hand activation, allowing surgeons to maintain control within the sterile field, enhancing operational efficiency.
• Blunt Tip and Straight Jaw: Features a blunt tip with a straight jaw design, providing precision in sealing and dividing vessels and tissue bundles up to 7 mm in diameter.
• Shaft Rotation: Offers less than 359° shaft rotation, enabling versatile maneuverability during surgery.

Performance Specifications

• Seal and Cut Length: Both seal and cut lengths measure 22 mm, with an average seal cycle of 2–4 seconds.
• Feedback-Controlled System: The device includes a feedback-controlled response system that automatically halts energy delivery upon completion of the seal cycle, ensuring reliable performance.
• Seal Integrity: Seals are robust, withstanding pressures up to three times normal systolic blood pressure.

Compatibility

• Energy Platform: Compatible with the ForceTriad Energy Platform, enhancing its versatility in surgical settings.

Technical Specifications

• Shaft Diameter: 10 mm
• Shaft Lengths: Available in two models:
• LS1020: 20 cm shaft length
• LS1037: 37 cm shaft length, featuring a seal width of 6 mm and a smooth surface with ceramic stops.
• Jaw Angle: Straight jaw angle for precise application.

Additional Features

• Single-Use and Sterile: Ensures hygiene and safety in surgical environments.
• Ergonomic Handle: Designed for comfortable and effective use, reducing fatigue during lengthy procedures.

The LigaSure Atlas Hand Switching Instrument is a crucial asset for surgical teams, providing reliable vessel fusion without the need for vessel dissection or isolation, thereby streamlining surgical workflows and enhancing patient outcomes.